Pharmaceutical News and Articles

Efzimfotase Alfa Demonstrated Positive Results From Global Phase III Clinical Programme in Hypophosphatasia

The efzimfotase alfa (ALXN1850) Phase III clinical programme, designed to study a broad hypophosphatasia (HPP) patient population, demonstrated positive results

Elevar Therapeutics Announces FDA Acceptance for Review of New Drug Application for Lirafugratinib as Second-line Cholangiocarcinoma Treatment

Adenoidectomy, Tonsillectomy in Childhood Tied to Risk for Adult Chronic Rhinosinusitis

Prior tonsillectomy and adenoidectomy in the setting of specific childhood conditions may be associated with increased rates of adult chronic rhinosinusitis (CR

SEEG-Guided Radiofrequency Thermocoagulation Beneficial for Pediatric Epilepsy

For pediatric patients with drug-resistant focal epilepsy, stereoelectroencephalography-guided radiofrequency thermocoagulation (SEEG-RFTC) is safe, with favora

FDA Approves Ponlimsi (denosumab-adet), a Biosimilar to Prolia

Cold Weather More Deadly For The Heart Than Heat, Study Finds

TUESDAY, March 31, 2026 Seniors and people with heart problems need to exercise more caution during cold snaps compared to heat waves, a new study says. Folks a

Short Bursts of Exercise Linked To Lower Risk of Major Diseases

TUESDAY, March 31, 2026 As it turns out, you don t need long workouts to improve your health. Just a few minutes of more intense activity each day may help lowe

Sex Enhancement Chocolates Recalled Over Hidden Drug Ingredients

TUESDAY, March 31, 2026 Two chocolate products marketed for sexual enhancement are being recalled because they were found to contain hidden prescription drug in

Over 10.2 Million Grill Brushes Recalled Over Metal Bristle Risk

TUESDAY, March 31, 2026 Millions of grill brushes are being recalled following reports that small metal bristles can break off and end up in food. The U.S. Cons

Global Maternal Mortality Ratio Reported at 190.5 Deaths/100,000 Livebirths in 2023

In 2023, the global maternal mortality ratio (MMR) was 190.5 maternal deaths per 100,000 livebirths, according to a study published online March 26 in The Lance